ZK Rollups Are Bleeding: Why Proving Costs Are the Bear Market's Silent Killer
0xBen
1/ The numbers don't lie. Over the past 30 days, the top three ZK Rollups—zkSync, StarkNet, and Scroll—collectively lost 45% of their sequencer revenue to proving costs. That's not a revenue problem. That's a structural debt problem. And in a bear market, debt kills.
2/ Let me be blunt: if you're holding ZK tokens based on the narrative that 'ZK is the endgame,' you're ignoring a balance sheet that's hemorrhaging cash. I've been auditing smart contracts since 2017, and I've seen this pattern before. High technical debt masked by enthusiasm. The market doesn't care about your thesis—it cares about your P&L.
3/ Context first. ZK Rollups batch transactions off-chain and generate a cryptographic proof (usually a SNARK or STARK) that gets verified on L1. The cost of generating that proof—proving cost—is paid by the operator. In bull markets, when gas prices are high and L1 congestion forces users to pay premium fees, the arithmetic works. Fees exceed proving cost. Operators profit.
4/ But in this bear market? Average Ethereum gas has slumped to 5-15 gwei. L1 settlements are cheap. Users won't pay a premium to use a rollup when they can settle directly on L1 for pennies. The result: rollup fees crash, but proving costs remain stubbornly high. They are denominated in compute, not in gas. The physics of proof generation doesn't scale down with market sentiment.
5/ Based on my team's internal analysis—we run a quant trading desk that also tracks L2 economics—here's the breakdown. zkSync's average proving cost per batch is around $2,500 (using GPU clusters). Their average revenue per batch? Under $400 in recent weeks. Negative margin of 84%. StarkNet is worse: $4,200 per batch vs $250 revenue. Scroll sits in the middle.
6/ I've seen this movie before. In DeFi Summer 2020, I deployed a high-frequency arbitrage bot between Uniswap and Sushiswap. When gas fees spiked, our strategy became unprofitable overnight. We pivoted to EIP-1559-compliant logic. But ZK operators can't pivot as easily. They are locked into a cost structure that's amortized over months, not days. Proof generation hardware doesn't uninstall itself.
7/ The contrarian angle is uncomfortable: maybe optimistic rollups, often dismissed as 'inferior tech,' are actually better positioned for a low-fee environment. Optimistic fraud proofs are cheap to produce—near zero marginal cost. Only disputes cost money. In a bear market, where speed is less critical and cost is everything, being 'good enough' beats being 'perfect but expensive.'
8/ Retail sees ZK as the holy grail. Smart money sees a cost curve that's inverted. I've been on the other side of that trade before—during the Terra collapse in 2022, I liquidated 100% of my portfolio 48 hours before the crash because I saw the unsustainable seigniorage mechanics. The same principle applies here: look at the incentive structures, not the narrative.
9/ Audit the code, but trust the incentives. The incentive for ZK operators right now is to subsidize proving costs with token treasuries or investor capital. That's not sustainable. Either fees recover (bull market), or proving costs drop by an order of magnitude (via hardware acceleration or algorithmic breakthroughs), or these networks consolidate or die.
10/ I've seen the math. Some teams are experimenting with recursive proofs that batch multiple ZK proofs into one—this could cut costs by 60-70%. But we're at least 6-12 months from production-ready implementations. In crypto, 6 months without profitability is a death sentence for anything that burns cash.
11/ Here's the takeaway: If you're trading ZK tokens, treat them as high-beta calls on Ethereum L1 fee recovery. Not as infrastructure plays. The fundamental value isn't there until proving costs fall below revenue sustainably. Until then, the market doesn't care about your thesis. It only respects your exit strategy.
12/ Arbitrage isn't always about price; sometimes it's about recognizing when a protocol's cost structure becomes a liability. That's the real trade. The market doesn't care about your thesis—it cares about your P&L. Audit the code, but trust the incentives.
13/ Have I been wrong before? Sure. But I haven't been wrong about the math. And the math says ZK Rollups are bleeding. Watch the proving cost per batch as a lead indicator. If it stays above revenue for another quarter, this narrative flips from 'promising tech' to 'legacy baggage.'